Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas

Genes Chromosomes and Cancer

Volumn 15, Issue 3, 1996, Pages 187-190

  Ohnishi, Hiroaki ^a   Kawamura, Machiko ^a   Hanada, Ryoji ^b   Kaneko, Yasuhiko ^c   Tsunoda, Yuko ^d   Hongo, Teruaki ^e   Bessho, Fumio ^a   Yokomori, Kinji ^a   Hayashi, Yasuhide ^a,f  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE; CHILD; CODON; DNA PRIMERS; EXONS; GENES, P53; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0029876852     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z     Document Type: Article

References (25)

1. Abenoza P, Manivel JC, Wich MR, Hagen K, Dehner LP (1987) Hepatoblastoma: An immunohistochemical and ultrastructural study. Human Pathol 18:1025-1035.
2. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, Van Tuinen P, Ledbetter DH, Baker DF, Nakamura Y, White R, Vogelstein, B (1989) Chromosome 17 deletions and TP53 gene mutations in colorectal carcinomas. Science 244:217-221.
3. Bardeesy N, Falkoff D, Pretruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours TP53 gene mutations. Nature Genet 7:91-97.
4. Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of TP53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431.
5. Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE, Henderson BE, Hammond GD (1989) A case-control study of risk factors for hepatoblastoma. A report from the Children's Cancer Study Group. Cancer 64:1169-1176.
6. Caron de Fromentel C, Soussi T (1992) TP53 Tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosom Cancer 4:1-15.
7. Debuire B, Paterlini P, Pontisso P, Basso G, and May E (1993) Analysis of the TP53 gene in European hepatocellular carcinomas and hepatoblastomas. Oncogene 8:2303-2306.
8. Dehner LP (1987) Liver, gallbladder and extrahepatic biliary tract. In Dehner LP (ed): Pediatric Surgical Pathology. Baltimore: Williams and Wilkins, pp 433-523.
9. Fraumeni JF, Miller RW, Hill JA (1968) Primary carcinoma of the liver in childhood: An epidemiologic study. JNCI 40:1087-1099.
10. Hartley AL, Birch JM, Kelsey AM, Jones PH, Harris M, Blair V (1990) Epidemiological and familial aspects of hepatoblastoma. Med Pediatr Oncol 18:103-109.
11. Hayashi K (1991) PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1:34-38.
12. Heimdal K, Lothe RA, Lystad S, Holm R, Fossa SD, Borresen AL (1993) No germ line TP53 mutation detected in familial and bilateral testicular cancer. Genes Chromosom Cancer 6:92-97.
13. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) TP53 mutations in human cancers. Science 253:49-53.
14. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the TP53 gene in human hepatocellular carcinomas. Nature 350:427-428.
15. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC (1993) TP53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14:987-992.
16. Ishak KG, Glunz PR (1967) Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 20:396-422.
17. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Hanada R, Yamamoto K, Hongo T, Yamada M, Tsuchida Y (1993) Mutations of the TP53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53: 5284-5288.
18. Koufos A, Hansen MF, Copeland NG Jenkins NA, Lampkin BC, Cavanee WK (1985) Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 316:330-334.
19. Lack EE, Neave C, Vawter CF (1982) Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 6:693-705.
20. Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991) Aberrations of the tumor suppressor TP53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520-5525.
21. Nigro J, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Binger SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in TP53 gene occur in diverse human tumour types. Nature 342:705-708.
22. Oda H, Nakatsuru Y, Imai Y, Sugimura H, Ishikawa T (1995) A mutational hot spot in the p53 gene is associated with hepatoblastomas. Int J Cancer 60:786-790.
23. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
24. Tsunoda Y, Shibusawa M, Choh H, Soejima K (1994) Biological characteristics of human hepatoblastoma transplanted in nude mice (abstract). Jpn J Cancer Res (Suppl)85:397.
25. Tsunoda Y, Shibusawa M, Okamatsu T, Yatsuzuka M, Iijima T, Soejima K (1996) Non-alpha-fetoprotein producing anaplastic hepatoblastoma - The character of the cell line. In Vitro (in press).